throbber
KALBITOR® (ecallantide) | Official KALBITOR® Site
`
`Page 1 of 4
`
`Proven symptom reduction for your HAE attacks
`In clinical trials, patients treated with KALBITOR showed significant
`improvement in hereditary angloedema (HAE) attack symptoms at 4 hours.
`
`LEARN MORE ABOUT KALBITOR › (/how-ka bitor-works)
`
`https://www kalbitor.com/
`
`11/29/2018
`
`Page 1 of 4
`
`CSL EXHIBIT 1075
`
`

`

`KALBITOR® (ecallantide) | Official KALBITOR® Site
`
`Page 2 of 4
`
`Please see Full Prescribing Information
`(http://www.shirecontent.com/PI/PDFs/Kalbitor USA ENG.pdf), including
`Boxed Warning and Medication Guide (http://www.shirecontent.com/?
`product=Kalbitor&country=USA&language=ENG&contenttype=medguide).
`
`
`
`
`
`Patient Ambassador Events
`Attend a live event and hear from someone with HAE. You can learn about his or her path to diagnosis and
`how they manage life with HAE.
`
`FIND AN EVENT NEAR YOU ›
`
`(/events)
`
`OnePath Product Support Services
`OnePath is here to support you throughout your treatment journey with KALBITOR.
`

`
`LEARN MORE ›
`
`(/onepath)
`
`Sign Up & Stay in Touch
`
`https://www.kalbitor.com/
`
`11/29/2018
`
`Page 2 of 4
`
`

`

`KALBITOR® (ecallantide) | Official KALBITOR® Site
`
`Page 3 of 4
`
`Register to receive more information from Shire about HAE.
`
`SIGN UP TODAY ›
`
`(/join)
`
`Important Safety Information
`What is the most important information I should know about KALBITOR?
`Serious allergic reactions may happen in some people who receive KALBITOR. These allergic reactions can
`be life-threatening and usually happen within 1 hour after receiving KALBITOR.
`
`• KALBITOR should be given to you by a doctor or nurse in a healthcare setting where
`serious allergic reactions and hereditary angioedema (HAE) can be treated.
`
`• Symptoms of a serious allergic reaction to KALBITOR can be similar to the symptoms
`of HAE, the condition that you are being treated for. Your doctor or nurse should
`watch you for any signs of a serious allergic reaction after treatment with KALBITOR.
`
`• Tell your doctor or nurse right away if you have any of these symptoms of a serious
`allergic reaction during or after treatment with KALBITOR:
`◦ wheezing, shortness of breath, cough, chest tightness, or trouble breathing
`◦ dizziness, fainting, fast or weak heartbeat, or feeling nervous
`◦ reddening of the face, itching, hives, or feeling warm
`◦ swelling of the throat or tongue, throat tightness, hoarse voice, or trouble
`swallowing
`◦ runny nose, nasal congestion, or sneezing
`Who should not receive KALBITOR?
`Do not receive KALBITOR if you are allergic to KALBITOR. Before receiving KALBITOR, tell your doctor if
`you have ever had an allergic reaction to KALBITOR.
`
`What else should I tell my doctor before I receive KALBITOR?
`Tell your doctor if you are pregnant, plan to become pregnant, breast-feeding, or plan to breast-feed. It is
`not known if KALBITOR will harm your unborn baby or pass into your breast milk.
`
`What are the possible side effects?
`Common side effects of KALBITOR include headache, nausea, diarrhea, fever, injection site reactions, such
`as redness, rash, swelling, itching, or bruising, and stuffy nose. You are encouraged to report negative side
`effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch (http://www.fda.gov/medwatch),
`or call 1-800-FDA-1088.
`
`Talk to your doctor for more information about your medical condition or treatment.
`
`https://www.kalbitor.com/
`
`11/29/2018
`
`Page 3 of 4
`
`

`

`KALBITOR® (ecallantide) | Official KALBITOR® Site
`
`Page 4 of 4
`
`Please see the Full Prescribing Information
`(http://www.shirecontent.com/PI/PDFs/Kalbitor_USA_ENG.pdf), including Boxed Warning and
`Medication Guide (http://www.shirecontent.com/?
`product=Kalbitor&country=USA&language=ENG&contenttype=medguide).
`
`(https://www.shire.com)
`
`Hereditary Angioedema
`
`TM or ® items and the associated logos are trademarks or registered trademarks of Shire or its affiliates.
`
`© 2017 Shire US Inc., Lexington, MA 02421 1-800-828-2088
`All rights reserved. SHIRE and the Shire Logo are trademarks or registered trademarks of Shire
`Pharmaceutical Holdings Ireland Limited or its affiliates.
`S28528 06/17
`
`https://www.kalbitor.com/
`
`11/29/2018
`
`Page 4 of 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket